ASX - By Stock
|
CYP |
Re:
Ann: Cynata Expands trial in COVID-19 & Respiratory Failure
|
|
Julee1
|
221 |
49K |
3 |
03/04/21 |
03/04/21 |
ASX - By Stock
|
221
|
49K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
Julee1
|
495 |
107K |
1 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
495
|
107K
|
1
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
0 |
06/09/20 |
06/09/20 |
Charts
|
345
|
93K
|
0
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
5 |
02/09/20 |
02/09/20 |
Charts
|
345
|
93K
|
5
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
3 |
01/09/20 |
01/09/20 |
Charts
|
345
|
93K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Appoints Dr Geoff Brooke as Chairman
|
|
Julee1
|
59 |
15K |
7 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
59
|
15K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Investor Presentation
|
|
Julee1
|
59 |
15K |
7 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
59
|
15K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Announces Positive Results from GvHD Trial Follow-up
|
|
Julee1
|
115 |
23K |
7 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
115
|
23K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Announces Positive Results from GvHD Trial Follow-up
|
|
Julee1
|
115 |
23K |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
115
|
23K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
2 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
274
|
75K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
3 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
274
|
75K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
1 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
274
|
75K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
6 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
274
|
75K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
6 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
274
|
75K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
5 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
274
|
75K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
274
|
75K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Cynata CEO Interview
|
|
Julee1
|
78 |
20K |
6 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
78
|
20K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
0 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
274
|
75K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
2 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
274
|
75K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
New chapter starts now?
|
|
Julee1
|
9 |
2.9K |
0 |
19/07/20 |
19/07/20 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
0 |
18/07/20 |
18/07/20 |
ASX - By Stock
|
274
|
75K
|
0
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
0 |
18/07/20 |
18/07/20 |
Charts
|
345
|
93K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
Julee1
|
495 |
107K |
6 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
495
|
107K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
0 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
274
|
75K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
5 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
274
|
75K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
3 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
274
|
75K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
1 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
274
|
75K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
3 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
274
|
75K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
3 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
274
|
75K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
6 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
274
|
75K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
5 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
274
|
75K
|
5
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
0 |
08/07/20 |
08/07/20 |
Charts
|
345
|
93K
|
0
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
1 |
07/07/20 |
07/07/20 |
Charts
|
345
|
93K
|
1
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
0 |
07/07/20 |
07/07/20 |
Charts
|
345
|
93K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
5 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
274
|
75K
|
5
|
|
Charts
|
CYP |
Re:
Chart - CYP
|
|
Julee1
|
345 |
93K |
3 |
06/07/20 |
06/07/20 |
Charts
|
345
|
93K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
0 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
274
|
75K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
1 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
274
|
75K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval to Commence Clinical Trial in COVID-19
|
|
Julee1
|
274 |
75K |
2 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
274
|
75K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Securities Dealing Policy
|
|
Julee1
|
22 |
4.8K |
0 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
22
|
4.8K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Securities Dealing Policy
|
|
Julee1
|
22 |
4.8K |
0 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
22
|
4.8K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Securities Dealing Policy
|
|
Julee1
|
22 |
4.8K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
22
|
4.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Securities Dealing Policy
|
|
Julee1
|
22 |
4.8K |
0 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
22
|
4.8K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
Julee1
|
507 |
1.5M |
9 |
27/06/20 |
27/06/20 |
ASX - By Stock
|
507
|
1.5M
|
9
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
Julee1
|
507 |
1.5M |
7 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
507
|
1.5M
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
Julee1
|
495 |
107K |
2 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
495
|
107K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
Julee1
|
495 |
107K |
12 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
495
|
107K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
SPP refund?
|
|
Julee1
|
15 |
3.6K |
0 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
15
|
3.6K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Block Trade Proceeds to Reduce Director Loans
|
|
Julee1
|
27 |
6.3K |
0 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
27
|
6.3K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Block Trade Proceeds to Reduce Director Loans
|
|
Julee1
|
27 |
6.3K |
0 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
27
|
6.3K
|
0
|
|